INBX Inhibrx Biosciences, Inc.

NASDAQ
$101.77

Inhibrx Biosciences, Inc. (INBX) SEC Filings

Everything INBX has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.

17 filings
Date Form Filing
4
144
144
144
4
144
144
4
4
4
8-K Investor Presentation · Other · Other Event · Other Reg Fd · Reg Fd
4
4
4
4
4
4

Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.